PKI News and Press, PerkinElmer Inc. From 01/31/20

Pfizer Misses Q4 Target, offers Soft Guidance Pfizer ( PFE ) stock stumbled as the company reported lower than expected numbers for its fourth quarter. It also provided lackluster guidance for the upcoming FY 2020. The company’s revenue fell as it lost exclusivity on its key drugs...

For a company with rich expectations embedded into the valuation, I’d say the reaction to fourth-quarter earnings and 2020 guidance from PerkinElmer ( PKI ) was fairly restrained. The stock has weakened a bit since earnings, but only after an impressive climb from under $80 in early O...

PerkinElmer ( PKI -2.7% ) is down on below-average volume after reporting Q4 and full-year results after the close yesterday. Earnings and revenue topped expectations , but soft 2020 guidance has dampened investor enthusiasm. More news on: PerkinElmer, Inc., Healthcare stocks new...

PerkinElmer (NYSE: PKI) entered 2020 with a pretty good head of steam. The global healthcare company saw its shares jump 24% last year. But there hasn't been a lot of news from PerkinElmer so far in January to move the stock either up or down -- until yesterday. The company announced its fi...

Image source: The Motley Fool. PerkinElmer Inc   (NYSE: PKI) Q4 2019 Earnings Call Jan 27, 2020 , 5:00 p.m. ET Operator Continue reading

PerkinElmer, Inc. (PKI) Q4 2019 Results Conference Call January 27, 2019 05:00 PM ET Company Participants Bryan Kipp - VP, IR Prahlad Singh - President and CEO Jamey Mock - SVP and CFO Conference Call Participants Catherine Schulte - Baird Dan Arias - Stifel Derik DeBru...

Gainers: XLRN   +79.4% . SURF   +17.2% . DESP   +8.7% . KBWB   +5.8% . BCRX   +4.4% . More news on: Acceleron Pharma Inc., Surface Oncology, Inc., Despegar.com, Corp., Stocks on the move, , , News on ETFs Read more ...

PerkinElmer (NYSE: PKI ) Q4 results : More news on: PerkinElmer, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...

PerkinElmer (NYSE: PKI ): Q4 Non-GAAP EPS of $1.35 beats by $0.02 ; GAAP EPS of $0.58 misses by $0.34 . More news on: PerkinElmer, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

4Q Revenue of $805.5 million; 6% reported growth; 5% organic growth 4Q GAAP EPS from continuing operations of $0.58; Adjusted EPS of $1.35 4Q GAAP operating income margin of 17.2%; Adjusted operating income margin from continuing operations of 23.9% Initiates FY20 GAAP E...